Hims & Hers

Injectable obesity weight loss
Telehealth

Telehealth booms on surging GLP-1 demand despite safety concerns

Primary care's poor track record on weight loss and past GLP-1 shortages have created a “perfect storm” for telehealth companies to flourish.
Hims Hers branded GLP-1

Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy

May 12, 2026 4:00pm
smartphones with screen shots of Labs AI feature

Hims & Hers debuts AI agent to help users interpret lab results

May 7, 2026 9:00am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Healthcare Dealmakers—Hims & Hers goes international and more

Mar 10, 2026 11:00am
Novo Nordisk Ozempic semaglutide

Hims & Hers makes deal with Novo in obesity strategy shift

Mar 9, 2026 10:53am
Hims Hers Super Bowl commercial

Hims & Hers downplays business impact of compounded GLP-1s

Feb 25, 2026 1:30pm